Winship researchers and colleagues from several health care systems and universities have discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy. The findings, which were recently published in the journal Science Advances, not only offer guidance for patients and their physicians making treatment decisions, but can also curtail the financial burden associated with immunotherapy.
A large first-of-its-kind study led by Winship member Xu Ji, PhD, MSPH (pictured), in collaboration with Winship members Xuesong Han, PhD, Ann Mertens, PhD, Sharon Castellino, MD, MSc, and others was featured in US News & World Report, The Hill, Health Day, Kaiser Health News and other outlets. The study finds that expanded Medicaid coverage under the Affordable Care Act leads to better survival outcomes for young adults aged 18-39 newly diagnosed with cancer, particularly those identified as of Hispanic ethnicity or non-Hispanic Black race.
Winship member Anant Madabhushi, PhD, has received a $600,000 grant from Bristol Myers Squibb for his project, “Integrated radiomics and pathomics to predict response to immune checkpoint inhibitors in non-small cell lung cancer from BMS Checkmate trials: validation study.” The grant builds on a decade of research, which Madabhushi describes in a November 2022 video interview with VJ Oncology.
Winship cardio-oncologist Anant Mandawat, MD, has been appointed to the American College of Cardiology Leadership Council on Cardiovascular Management. In this role, he will provide expertise on the structure and development of cardio-oncology services in the U.S.
U.S. Congressman Jamie Raskin announced in December that he was diagnosed with diffuse large B-cell lymphoma. In a USA Today video, Winship hematologist Edmund K. Waller, MD, PhD, describes the disease and potential treatment outcomes.
In an OncLive video, Winship Executive Director Suresh Ramalingam, MD, and colleagues discuss second-line treatment options for patients with non-small cell lung cancer who progressed on first-line EGFR-directed tyrosine kinase inhibitors.
In an OncLive video, Winship oncologist Jane Meisel, MD, discusses HER2-low classification, including the importance of assessing HER2 status in patients with metastatic breast cancer, particularly as more HER2-targeted agents are developed in clinical trials and evaluated in different patient populations.
In a recent episode of The Oncology Nursing Podcast, Winship’s Director of Spiritual Health Caroline Peacock, LCSW, BCC, ACPE, discusses spirituality in cancer care. Nurses can earn free contact hours after listening to this episode and completing the evaluation.
Join a multidisciplinary group of Emory practitioners for a symposium on the early detection of lung cancer using robotics technology at Emory Saint Joseph’s Hospital on Tuesday, Jan. 17, 5:30 - 8:30 p.m. This free continuing education event will discuss state-of-the-art robotic bronchoscopy and how this new tool is improving outcomes for patients.
Have a story for Winship Weekly? Submit your news here.
About Winship Cancer Institute of Emory University The coordinating center for cancer research, education and care throughout Emory University and Emory Healthcare, Winship Cancer Institute of Emory University is Georgia’s only National Cancer Institute-designated Comprehensive Cancer Center, a prestigious distinction given only to the top 3% of cancer centers nationwide for conducting cancer research, and providing training, that is transforming cancer care, prevention, detection and survivorship.